Catheter Production Articles & Analysis
18 news found
MedSource Labs, a class II medical device company headquartered in Minnesota, and Harsoria, an innovative manufacturer based in India, announced today the formation of Medsoria, their joint venture to expand production of peripheral IV catheters near Delhi, India. Together as Medsoria, the joint venture will increase production capabilities with ...
As a global company dedicated to innovation in medical devices, we recognized that representation matters—not just in our workforce, but in the way we present our products. During the production of our IV Catheter video animation, we worked with the animators to showcase a diverse range of skin tones. ...
By providing a range of testing services for Class I, II, and III medical devices, STEMart helps clients navigate the complex regulatory landscape and bring their products to market with confidence. Balloons and catheters, in particular, necessitate stringent testing to verify their intended use and labeling. ...
BySTEMart
MedSource Labs Moves the Needle in the Peripheral Safety IV Market With the announcement of ClearSafe Comfort® and TrueSafe Comfort® Blood Control IV Catheters with groundbreaking active check valve ...
“The acquisition of MateraCor, Inc., and their lead product, Trans-Catheter Myocardial Restoration (TCMR), reinforces our position to treat left ventricular heart failure by offering a variety of solutions that will directly impact ventricular remodeling through less invasive LV restoration ...
The Singapore site has been serving the medical device industry since 2004, focusing on minimally invasive products such as catheters and access sheaths, making this very compatible and complementary. ...
The company’s portfolio comprises two core products, the Walrus Balloon Guide Catheter (BGC) system, and the Wahoo Control™ Catheter hybrid access system. ...
Business Development In April 2021, the Company entered into an agreement with a Japanese therapeutic partner related to the Helix biotherapeutic delivery product candidates. Under the terms of the agreement, BioCardia received $500,000, a portion of which is creditable for biotherapeutic delivery products and support services. The agreement has a one-year ...
Q’Apel’s portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. ...
The company’s portfolio comprises two core products, the Walrus Balloon Guide Catheter (BGC) system, and the Wahoo Control™ Catheter hybrid access system. ...
Q’Apel’s core portfolio comprises two products, the Walrus Balloon Catheter System and the Wahoo Hybrid Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. ...
The company’s portfolio comprises two core products, the Walrus Balloon Guide Catheter (BGC) system, and the Wahoo Control™ Catheter hybrid access system. ...
Without this feature of post deployment, on demand shape changing, to achieve a similar pitch of the impeller blade would require a housing catheter as large as 22 FR size. This shape memory twist allows the device to be deployed through a considerably smaller, 13.8FR catheter. ...
” Richardson further stated, “These studies, again, give evidence to the advantages of the unique design for our catheter-based product. Furthermore, we have adapted this same mechanical stent and impeller pump platform for use in our chronic wireless device, which we are actively building and testing, to target additional therapeutic ...
(“Orchestra BioMed” or the “Company”), a biomedical innovation company developing transformative therapeutic products for large unmet needs in procedure-based medicine, today announced the appointment of Bob Laughner, an expert in global regulatory affairs for combination products, as Vice President, Regulatory Affairs. ...
The Right Approach Bundle, PIV5Rights, consisted of P=Proficiency, I=Insertion, V=Vein and Catheter, 5=Supplies & Technology and R=Review & Assessment. A few key aspects of the bundle were the use of a trained team (VAST), utilizing the right vein, correct catheter size and the use of designated products. ...
” Imperative Care’s first products are neurovascular access catheters designed to enable smooth, consistent navigation deep into blood vessels of the brain, which can be challenging because of the brain’s highly complex and twisted vascular structure. ...
(Sofregen), an early stage commercial biotechnology company developing products for medical aesthetics and reconstructive surgery, announced today that Silk Voice has been cleared by the U.S. ...